📊 XAIR Key Takeaways
Is Beyond Air, Inc. (XAIR) a Good Investment?
Beyond Air demonstrates exceptional revenue growth (2434% YoY) and improving loss metrics, indicating early commercial traction in medical devices. However, the company exhibits fundamental financial distress: negative operating cash flow of -$18.1M, unsustainable gross margins of 3.3%, and a 3.53x debt-to-equity ratio with negative interest coverage, indicating inability to service debt from operations. At the current -$19.2M free cash flow burn rate, cash runway is approximately 4-5 quarters without additional capital raises.
Revenue grew rapidly from a very small base, but the 3.3% gross margin indicates that current sales provide almost no contribution toward substantial operating costs. Deep losses, severe cash burn, high leverage, and limited equity create significant financing and dilution risk despite adequate near-term liquidity.
Beyond Air, Inc. Key Strengths (XAIR)
- Explosive revenue growth of 2434% year-over-year demonstrates strong market adoption and commercial validation
- Improving loss trajectory with net loss down 3.2% YoY and EPS improving 70.9% YoY suggests operational leverage emerging
- Strong liquidity ratios (3.80x current, 3.59x quick) with $6.7M cash position provides near-term financial flexibility
- Revenue increased 2434.3% year over year, demonstrating early commercial traction
- Current and quick ratios of 3.80x and 3.59x indicate adequate near-term liquidity
- Diluted EPS improved materially year over year
XAIR Stock Risks: Beyond Air, Inc. Investment Risks
- Negative free cash flow of -$19.2M is unsustainable; company burns cash faster than generates from operations
- Critically low gross margin of 3.3% and operating margin of -378.2% indicate product economics or cost structure issues requiring resolution
- High financial leverage (3.53x debt-to-equity, 21.6M long-term debt) combined with -10.0x interest coverage means company cannot service debt from operations and faces refinancing risk
- Operating and net margins of -378.2% and -433.0% show an economically unsustainable cost structure
- Negative free cash flow of $19.17 million substantially exceeds the $6.74 million cash balance
- Debt of $21.64 million, debt-to-equity of 3.53x, and negative interest coverage create substantial solvency and refinancing risk
Key Metrics to Watch
- Gross margin expansion trajectory and path to breakeven contribution margin
- Operating cash flow inflection point and timeline to positive operating cash generation
- Cash runway duration and need for capital raise or debt restructuring given -$19.2M annual FCF burn
- Gross margin and operating cash burn
- Cash balance and additional financing requirements
Beyond Air, Inc. (XAIR) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 3.80x current ratio provides a solid financial cushion.
XAIR Profit Margin, ROE & Profitability Analysis
XAIR vs Healthcare Sector: How Beyond Air, Inc. Compares
How Beyond Air, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Beyond Air, Inc. Stock Overvalued? XAIR Valuation Analysis 2026
Based on fundamental analysis, Beyond Air, Inc. shows some fundamental concerns relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Beyond Air, Inc. Balance Sheet: XAIR Debt, Cash & Liquidity
XAIR Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Beyond Air, Inc.'s revenue has grown significantly by 452% over the 5-year period, indicating strong business expansion. The most recent EPS of $-13.77 indicates the company is currently unprofitable.
XAIR Revenue Growth, EPS Growth & YoY Performance
XAIR Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2027 | $1.8M | -$7.7M | $-11.00 |
| Q3 2026 | $1.1M | -$7.3M | $-0.85 |
| Q2 2026 | $798.0K | -$7.9M | $-1.25 |
| Q1 2026 | $683.0K | -$7.7M | $-1.53 |
| Q3 2025 | $391.0K | -$13.0M | $-0.15 |
| Q3 2024 | $391.0K | -$12.7M | $-0.43 |
| Q2 2024 | $239.0K | -$12.0M | $-0.28 |
| Q1 2024 | $59.0K | -$10.9M | $-0.27 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Beyond Air, Inc. Dividends, Buybacks & Capital Allocation
XAIR SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Beyond Air, Inc. (CIK: 0001641631)
📋 Recent SEC Filings
❓ Frequently Asked Questions about XAIR
What is the AI rating for XAIR?
Beyond Air, Inc. (XAIR) has a Combined AI Grade of C from Claude (C) and ChatGPT (D) with 89% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are XAIR's key strengths?
Claude: Explosive revenue growth of 2434% year-over-year demonstrates strong market adoption and commercial validation. Improving loss trajectory with net loss down 3.2% YoY and EPS improving 70.9% YoY suggests operational leverage emerging. ChatGPT: Revenue increased 2434.3% year over year, demonstrating early commercial traction. Current and quick ratios of 3.80x and 3.59x indicate adequate near-term liquidity.
What are the risks of investing in XAIR?
Claude: Negative free cash flow of -$19.2M is unsustainable; company burns cash faster than generates from operations. Critically low gross margin of 3.3% and operating margin of -378.2% indicate product economics or cost structure issues requiring resolution. ChatGPT: Operating and net margins of -378.2% and -433.0% show an economically unsustainable cost structure. Negative free cash flow of $19.17 million substantially exceeds the $6.74 million cash balance.
What is XAIR's revenue and growth?
Beyond Air, Inc. reported revenue of $7.7M.
Does XAIR pay dividends?
Beyond Air, Inc. does not currently pay dividends.
Where can I find XAIR SEC filings?
Official SEC filings for Beyond Air, Inc. (CIK: 0001641631) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is XAIR's EPS?
Beyond Air, Inc. has a diluted EPS of $-4.01.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is XAIR's fundamental grade?
Based on our AI fundamental analysis in August 2026, Beyond Air, Inc. has a C grade with 89% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is XAIR stock overvalued or undervalued?
Valuation metrics for XAIR: ROE of -542.8% (sector avg: 15%), net margin of -433.0% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is XAIR's AI grade for 2026?
Our dual AI analysis gives Beyond Air, Inc. a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is XAIR's free cash flow?
Beyond Air, Inc.'s operating cash flow is $-18.1M, with capital expenditures of $1.0M. FCF margin is -249.6%.
How does XAIR compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -433.0% (avg: 12%), ROE -542.8% (avg: 15%), current ratio 3.80 (avg: 2).
Is Beyond Air, Inc. carrying too much debt?
XAIR has a debt-to-equity ratio of 3.53x, which is above the Healthcare sector average of 0.6x. However, the current ratio of 3.80 suggests adequate short-term liquidity.